MENU
+Compare
WGS
Stock ticker: NASDAQ
AS OF
Sep 26 closing price
Price
$117.21
Change
+$4.25 (+3.76%)
Capitalization
3.37B

WGS GeneDx Holdings Corp Forecast, Technical & Fundamental Analysis

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery... Show more

WGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for WGS with price predictions
Sep 26, 2025

WGS in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 24, 2025

WGS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 39 cases where WGS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

WGS moved above its 50-day moving average on September 26, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WGS advanced for three days, in of 260 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 174 cases where WGS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for WGS moved out of overbought territory on September 08, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on September 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on WGS as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for WGS turned negative on August 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WGS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. WGS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.151) is normal, around the industry mean (9.475). WGS's P/E Ratio (1465.125) is considerably higher than the industry average of (134.683). WGS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.660). WGS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (9.234) is also within normal values, averaging (9.241).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WGS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
WGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

WGS is expected to report earnings to fall 22.80% to 38 cents per share on November 17

GeneDx Holdings Corp WGS Stock Earnings Reports
Q3'25
Est.
$0.39
Q2'25
Beat
by $0.38
Q1'25
Missed
by $0.29
Q4'24
Beat
by $0.56
Q2'23
Missed
by $0.33
The last earnings report on July 29 showed earnings per share of 50 cents, beating the estimate of 11 cents. With 436.65K shares outstanding, the current market capitalization sits at 3.37B.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
333 Ludlow Street
Phone
+1 888 729-1206
Employees
1000
Web
https://www.genedx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LBWAX22.540.20
+0.90%
BrandywineGLOBAL Div US Large Value A
CDIRX36.680.25
+0.69%
Columbia Dividend Income R
GQEIX21.810.15
+0.69%
GQG Partners US Select Quality Eq Instl
ETIMX15.000.08
+0.54%
Eventide Balanced Fund Class I
IGMAX8.130.04
+0.49%
Voya Global Insights Portfolio ADV

WGS and Stocks

Correlation & Price change

A.I.dvisor tells us that WGS and OPK have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that WGS and OPK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WGS
1D Price
Change %
WGS100%
+3.76%
OPK - WGS
31%
Poorly correlated
+1.40%
ATEN - WGS
28%
Poorly correlated
+0.55%
CDNA - WGS
28%
Poorly correlated
+0.40%
GCT - WGS
25%
Poorly correlated
+2.77%
CDNS - WGS
24%
Poorly correlated
-0.27%
More

Groups containing WGS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WGS
1D Price
Change %
WGS100%
+3.76%
Medical Specialties
industry (83 stocks)
27%
Poorly correlated
+6.48%